Target Blood Pressure in Pregnancy
For pregnant women with hypertension, the target blood pressure is a diastolic BP of 85 mmHg and systolic BP of 110-140 mmHg (or <140/90 mmHg), with treatment initiated when BP reaches ≥140/90 mmHg in the office (or ≥135/85 mmHg at home).
Treatment Initiation Thresholds
The most recent high-quality guidelines consistently recommend starting antihypertensive therapy at ≥140/90 mmHg for all hypertensive disorders of pregnancy 1, 2, 1. This applies to:
- Chronic hypertension
- Gestational hypertension
- Preeclampsia
The 2025 AHA/ACC guidelines and recent meta-analysis 3 support this threshold, demonstrating that treating to <140/90 mmHg significantly reduces severe hypertension (RR 0.477), preeclampsia (RR 0.819), and preterm birth <37 weeks (RR 0.856) without adverse fetal effects.
Target Blood Pressure Range
The optimal target is:
This target is based on the landmark CHIPS trial, which demonstrated that targeting a diastolic BP of 85 mmHg reduced severe maternal hypertension without adverse neonatal outcomes 4. The CHAP trial further validated treating chronic hypertension to <140/90 mmHg, showing reduced composite adverse outcomes (OR 0.82) including preeclampsia with severe features and indicated preterm birth 5.
Critical Safety Parameters
Reduce or cease antihypertensives if diastolic BP falls <80 mmHg 1. This prevents excessive BP lowering that could compromise placental perfusion.
Severe hypertension (≥160/110 mmHg) is an obstetrical emergency requiring urgent treatment within 30-60 minutes in a monitored setting 1, 2, 6. Acceptable agents include:
- Oral nifedipine (immediate-acting)
- IV labetalol
- IV hydralazine
First-Line Medications
For maintenance therapy, acceptable first-line agents include 2, 1:
- Oral labetalol
- Oral methyldopa
- Long-acting oral nifedipine
- Other beta-blockers (metoprolol, pindolol, propranolol)
Avoid ACE inhibitors and ARBs completely - they are contraindicated due to fetotoxicity 2.
Key Clinical Pitfalls
White coat hypertension is common in pregnancy 7. Consider home BP monitoring (target ≥135/85 mmHg) or ambulatory monitoring to confirm diagnosis before initiating treatment.
Do not withhold treatment in gestational hypertension or preeclampsia waiting for "severe" readings. The evidence now supports treating at 140/90 mmHg across all hypertensive disorders of pregnancy 1, 3.
Monitor closely for progression. Even with treatment, 25-30% of gestational hypertension cases progress to preeclampsia 1.
Postpartum follow-up is essential. Check BP within 3-10 days of discharge, as women with any hypertensive disorder of pregnancy remain at increased cardiovascular risk long-term 6, 5.
The evidence strongly supports a proactive treatment approach targeting 110-140/85 mmHg to optimize both maternal and fetal outcomes while preventing severe hypertensive complications.